ArticleInternational journal of molecular sciences2024

Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.

Raquel Sainz-Amo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.